Pluri (PLUR) Current Assets (2011 - 2025)
Pluri (PLUR) posted quarterly Current Assets of $13.8 million for Q4 2025, down 38.29% year-over-year from $22.4 million in Q4 2024, and down 18.42% quarter-over-quarter from $16.9 million in Q3 2025.
Pluri (PLUR) Current Assets (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Current Assets for 15 consecutive years, with $13.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets fell 38.29% year-over-year to $13.8 million; the TTM figure through Dec 2025 stood at $13.8 million (down 38.29% YoY), while the FY2025 annual figure was $22.1 million, down 28.97% from the prior year.
- Current Assets slipped to $13.8 million in Q4 2025 per PLUR's latest filing, from $16.9 million in the prior quarter.
- Across five years, Current Assets topped out at $67.4 million in Q2 2021 and bottomed at $13.8 million in Q4 2025.
- Historically, Current Assets has averaged $40.3 million across 5 years, with a median of $38.3 million in 2023.
- Annual changes were most pronounced in 2021 — Current Assets surged 179.59% — and 2024, when it plunged 41.38%.
- Pluri's Current Assets stood at $60.2 million in 2021, then declined by 16.65% to $50.1 million in 2022, then tumbled by 35.68% to $32.3 million in 2023, then tumbled by 30.64% to $22.4 million in 2024, then plunged by 38.29% to $13.8 million in 2025.
- Business Quant data shows PLUR's Current Assets at $13.8 million in Q4 2025, $16.9 million in Q3 2025, and $22.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Pluri | 16.11 Mn | 3.63 Mn | 86,000.00 | 13.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.80 Mn |
| Sep 30, 2025 | 16.92 Mn |
| Jun 30, 2025 | 22.10 Mn |
| Mar 31, 2025 | 27.46 Mn |
| Dec 31, 2024 | 22.37 Mn |
| Sep 30, 2024 | 27.03 Mn |
| Jun 30, 2024 | 31.11 Mn |
| Mar 31, 2024 | 27.37 Mn |
| Dec 31, 2023 | 32.25 Mn |
| Sep 30, 2023 | 35.26 Mn |
| Jun 30, 2023 | 41.41 Mn |
| Mar 31, 2023 | 46.69 Mn |
| Dec 31, 2022 | 50.14 Mn |
| Sep 30, 2022 | 49.72 Mn |
| Jun 30, 2022 | 57.75 Mn |
| Mar 31, 2022 | 64.31 Mn |
| Dec 31, 2021 | 60.15 Mn |
| Sep 30, 2021 | 62.83 Mn |
| Jun 30, 2021 | 67.37 Mn |
| Mar 31, 2021 | 49.82 Mn |